A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma.
about
A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
A Randomized Phase II Trial of ...... alignant Pleural Mesothelioma.
@en
A Randomized Phase II Trial of ...... alignant Pleural Mesothelioma.
@nl
type
label
A Randomized Phase II Trial of ...... alignant Pleural Mesothelioma.
@en
A Randomized Phase II Trial of ...... alignant Pleural Mesothelioma.
@nl
prefLabel
A Randomized Phase II Trial of ...... alignant Pleural Mesothelioma.
@en
A Randomized Phase II Trial of ...... alignant Pleural Mesothelioma.
@nl
P2093
P2860
P1476
A Randomized Phase II Trial of ...... alignant Pleural Mesothelioma.
@en
P2093
Andreas Rimner
Anne S Tsao
Daniel Gomez
David A Scheinberg
David Rice
Katherine Panageas
Lee M Krug
Marjorie G Zauderer
Michelle S Ginsberg
Prasad S Adusumilli
P2860
P304
P356
10.1158/1078-0432.CCR-17-2169
P407
P577
2017-09-28T00:00:00Z